THE HAGUE, The Netherlands, Sept. 1, 2022 /PRNewswire/ Following its July acquisition of a majority stake in Affidea, the largest European provider of advanced diagnostics, outpatient and
/PRNewswire/ Following its July acquisition of a majority stake in Affidea, the largest European provider of advanced diagnostics, outpatient and cancer.